The global Point-of-Care Molecular Diagnostics Market is poised for substantial growth as healthcare providers increasingly adopt rapid molecular testing solutions that enable faster clinical decision-making across hospitals, outpatient centers, and home healthcare settings. “According to a recent study by SNS Insider, the global Point-of-Care Molecular Diagnostics Market size valued at USD 4.86 billion in 2025, is anticipated to grow to USD 13.05 billion by 2035, registering a CAGR of 10.39% over the 2026–2035 forecast period.”
The global health care delivery system is gradually adopting a decentralized diagnosis process that is capable of providing reliable results faster and close to the patient. This development, alongside the need for efficiency in the diagnostic processes, the accessibility of health care delivery services, and advancements in technology, presents good conditions for market expansion.
The increasing adoption of compact molecular testing platforms is also enabling healthcare professionals to deliver laboratory-quality results in diverse clinical environments, improving patient management while supporting more efficient healthcare delivery.
To Get Detailed Insights on the Point-of-Care Molecular Diagnostics Market – Request a Sample Report
Portable Molecular Technologies Transform Modern Diagnostics
The fast pace of development of molecular biology techniques, miniaturization of equipment, and automation of testing has impacted the field of diagnostics in a number of ways. New, highly mobile devices that combine precision of analysis with ease of use allow healthcare providers to conduct molecular analysis beyond the laboratory environment.
The integration of these tools into connected healthcare platforms is also contributing to their popularity by providing data interoperability, integration into electronic medical records, and remote patient monitoring capabilities.
Growing investments in decentralized healthcare infrastructure and digital health technologies are expected to further expand the role of point-of-care molecular diagnostics across a wide range of clinical applications.
Key Market Findings Highlight Emerging Opportunities
Among technology categories, PCR-based tests accounted for 50% of global market revenue in 2025, reflecting their widespread clinical acceptance and strong analytical performance across multiple diagnostic applications.
Meanwhile, isothermal amplification-based tests are projected to emerge as the fastest-growing technology segment through 2035, driven by increasing demand for portable, simplified molecular testing solutions that require minimal laboratory infrastructure.
By application, infectious disease testing represented 45% of total market revenue in 2025, supported by growing utilization across emergency care, outpatient services, and public health programs. At the same time, oncology testing is expected to record the fastest growth during the forecast period, reflecting increasing emphasis on precision medicine, early disease detection, and biomarker-guided treatment strategies.
Healthcare providers continue expanding testing beyond conventional clinical settings. Hospitals accounted for 55% of market revenue in 2025, while home testing is anticipated to witness the fastest growth through 2035, supported by increasing consumer preference for convenient diagnostic solutions and the continued expansion of virtual healthcare services.
From a product perspective, cartridge-based disposable kits captured 48% of global revenue in 2025, reflecting their ease of use and standardized workflows. Meanwhile, lab-on-a-chip platforms are projected to experience the strongest growth over the coming decade, driven by advances in microfluidics, automation, and highly integrated diagnostic systems.
Decentralized Healthcare Continues to Drive Industry Expansion
Medical practitioners are becoming more focused on diagnostic tools that can provide accurate results fast without the need to depend on laboratory setup. The change is aiding wider acceptance in community healthcare clinics, ambulatory settings, emergency care units, and remote healthcare settings.
Increasing use of telemedicine, electronic health care services, and home care services is raising the requirement for portable molecular diagnostics systems that will aid faster decision making. The trend is predicted to be one of the most powerful drivers in the future.
Regional Markets Present Significant Growth Potential
The share of North America was 43.42%, backed by well-developed healthcare facilities, implementation of novel diagnostics technologies, and heavy investment in precision medicine solutions. Further commercialization efforts and positive regulatory policies are contributing toward the leading position of the region.
On the other hand, the Asia Pacific is estimated to be the fastest-growing region, growing at a CAGR of 15.82% till 2035. The increasing healthcare investments, growth in outpatient services, high awareness about diagnostics, and fast adoption of decentralized healthcare technologies are generating lucrative prospects in the region.
Leading Companies Continue to Advance Molecular Innovation
Competition within the point-of-care molecular diagnostics market remains highly dynamic as manufacturers focus on expanding product portfolios, strengthening global distribution networks, and introducing next-generation diagnostic platforms designed for decentralized healthcare environments.
Key companies operating in the global point-of-care molecular diagnostics market include Abbott Laboratories, Roche Diagnostics, Danaher Corporation, bioMérieux, QIAGEN, Thermo Fisher Scientific, QuidelOrtho, Hologic, Becton Dickinson, and Siemens Healthineers.
An SNS Insider analyst Parry Kardani commented, "Point-of-care molecular diagnostics are redefining how healthcare providers approach disease detection by delivering laboratory-quality testing closer to patients. Continued advances in miniaturization, automation, and digital connectivity are expected to expand clinical applications while supporting broader access to precision diagnostics worldwide."
About the Author
Get in touch
